Skip to content

Clinical trials

Fatty Liver trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fatty Liver Country / region: Taiwan Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20082
20111
20121
20181
20202
20212
20231
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Completed5
Unknown status4
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital4
Far Eastern Memorial Hospital3
89bio, Inc.2
Sanofi2
Chang Gung Memorial Hospital1
Dalin Tzu Chi General Hospital1
Eli Lilly and Company1
Fu Jen Catholic University Hospital1
National Cheng-Kung University Hospital1
Shih Chien University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fatty Liver18
Non-alcoholic Fatty Liver Disease7
Diabetes Mellitus2
Digestive System Diseases2
Fibrosis2
Liver Cirrhosis2
Liver Diseases2
Metabolic Diseases2
Obesity2
Acquired Immunodeficiency Syndrome1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.